When
04/04/24 8:00 AM
04/04/24 6:00 PM
America/New_York
Global Summit: mRNA’s Path Forward
<strong>About the event</strong><br>
The Alliance for mRNA Medicines invites you to participate in a global summit focused on the most pressing regulatory issues impacting mRNA technologies.<br>
At this summit, regulatory, industry, and academic leaders will present and discuss the opportunities for harmonizing the regulatory framework for mRNA. The leaders will detail the specific opportunities involving vaccines, therapeutics, and manufacturing.<br>
<strong></strong><br>
<strong>Why attend?</strong><br>
The summit offers a unique opportunity for meaningful knowledge exchange, discussion, and interaction between regulators and attendees on timely and relevant issues. Attendees will:<br>
<ul><li>Learn more from regulators about the areas most ripe for harmonization</li><li>Better understand the viewpoints of industry and academic leaders working through the same issues</li><li>Lay the groundwork for continued collaboration in this critical area</li></ul>
<br>
<strong></strong><strong>About AMM</strong><br>
The Alliance for mRNA Medicines (AMM) is the leading global organization dedicated to advancing and advocating for mRNA and next-generation encoding RNA therapeutics and vaccines for the benefit of patients, public health, and society. Our mission is to propel the future of mRNA medicine, improve patients’ lives, and advance scientific knowledge by convening and empowering the mRNA community, including industry leaders, innovators, scientists, and other key stakeholders.<br>
<br>
<strong>Transfers, Cancellations and Refunds Policy</strong><br>
Registrants may transfer their registration to another person at any time by notifying AMM at (<a href="mailto:AMM@healthmanagement.com">AMM@healthmanagement.com</a>) in writing. <br>
<br>
Cancellations must be made in writing to Lindsey Beck (<a href="mailto:lbeck@healthmanagement.com">lbeck@healthmanagement.com</a>). Refunds minus a 20% service charge are available for cancellations received in writing 14 days or more prior to the start of the event. No...
Leavitt Partners, LLC 601 New Jersey Avenue Northwest, STE 350, Washington, D.C. 20001 United States
Harmonizing the Regulatory Pathway for mRNA Vaccines and Therapeutics
Clay.Alspach@leavittpartners.com
false
MM/DD/YYYY
Apr
04
Thu, Apr 4, 2024, 8:00 AM — 6:00 PM EDT
Where
601 New Jersey Avenue Northwest, STE 350, Washington, D.C. 20001 United States
About the event
The Alliance for mRNA Medicines invites you to participate in a global summit focused on the most pressing regulatory issues impacting mRNA technologies.
At this summit, regulatory, industry, and academic leaders will present and discuss the opportunities for harmonizing the regulatory framework for mRNA. The leaders will detail the specific opportunities involving vaccines, therapeutics, and manufacturing.
Why attend?
The summit offers a unique opportunity for meaningful knowledge exchange, discussion, and interaction between regulators and attendees on timely and relevant issues. Attendees will:
About AMM
The Alliance for mRNA Medicines (AMM) is the leading global organization dedicated to advancing and advocating for mRNA and next-generation encoding RNA therapeutics and vaccines for the benefit of patients, public health, and society. Our mission is to propel the future of mRNA medicine, improve patients’ lives, and advance scientific knowledge by convening and empowering the mRNA community, including industry leaders, innovators, scientists, and other key stakeholders.
Transfers, Cancellations and Refunds Policy
Registrants may transfer their registration to another person at any time by notifying AMM at (AMM@healthmanagement.com) in writing.
Cancellations must be made in writing to Lindsey Beck (lbeck@healthmanagement.com). Refunds minus a 20% service charge are available for cancellations received in writing 14 days or more prior to the start of the event. No refunds are available thereafter.
This event is not open to the media.
The Alliance for mRNA Medicines invites you to participate in a global summit focused on the most pressing regulatory issues impacting mRNA technologies.
At this summit, regulatory, industry, and academic leaders will present and discuss the opportunities for harmonizing the regulatory framework for mRNA. The leaders will detail the specific opportunities involving vaccines, therapeutics, and manufacturing.
Why attend?
The summit offers a unique opportunity for meaningful knowledge exchange, discussion, and interaction between regulators and attendees on timely and relevant issues. Attendees will:
- Learn more from regulators about the areas most ripe for harmonization
- Better understand the viewpoints of industry and academic leaders working through the same issues
- Lay the groundwork for continued collaboration in this critical area
About AMM
The Alliance for mRNA Medicines (AMM) is the leading global organization dedicated to advancing and advocating for mRNA and next-generation encoding RNA therapeutics and vaccines for the benefit of patients, public health, and society. Our mission is to propel the future of mRNA medicine, improve patients’ lives, and advance scientific knowledge by convening and empowering the mRNA community, including industry leaders, innovators, scientists, and other key stakeholders.
Transfers, Cancellations and Refunds Policy
Registrants may transfer their registration to another person at any time by notifying AMM at (AMM@healthmanagement.com) in writing.
Cancellations must be made in writing to Lindsey Beck (lbeck@healthmanagement.com). Refunds minus a 20% service charge are available for cancellations received in writing 14 days or more prior to the start of the event. No refunds are available thereafter.
This event is not open to the media.